Highlights•The studies of rapid maxillary expansion in obstructive sleep apnea children's treatment are based on low-quality evidence.•Management decisions should be linked to the phenotype, considering outcomes beyond the apnea-hypopnea index.•A health policy is needed focusing on respiratory disorders prevention.